By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Verastem, Inc. 

215 First Street
Suite 440
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-858-0338 Fax: n/a


SEARCH JOBS








Company News
Verastem (VSTM) Names Gregory I. Berk, MD As Chief Medical Officer 4/19/2016 11:39:23 AM
Verastem (VSTM) Co-Founder, Dr. Robert Weinberg, Recognized With Two Prestigious Cancer Research Awards 4/18/2016 11:03:44 AM
Verastem (VSTM) Announces Presentation Of Scientific Data Supporting FAK Inhibition In Combination With Immunotherapy At The Keystone Symposium On Cancer Pathophysiology 3/31/2016 11:30:38 AM
Verastem (VSTM) Announces Presentation Of Scientific Data Supporting FAK Inhibition In Combination With Immunotherapy At The Keystone Symposium On Cancer Pathophysiology 3/31/2016 10:59:42 AM
Verastem (VSTM) Announces Oral Presentation Of Data Supporting The Preferential Targeting Of Ovarian Cancer Stem Cells At The Society Of Gynecologic Oncology’s 2016 Annual Meeting On Women’s Cancer 3/23/2016 10:01:35 AM
Verastem (VSTM) To Present Data Supporting FAK/PYK2 Inhibition At The 2016 AACR Annual Meeting 3/17/2016 9:34:32 AM
Verastem (VSTM) To Present Scientific Data Supporting FAK And PI3K/mTOR Inhibition To Target Cancer Stem Cells At The Keystone Symposium On Stem Cells And Cancer 3/10/2016 11:13:39 AM
Verastem (VSTM) To Present At 28th Annual ROTH Conference 3/8/2016 10:19:06 AM
Verastem (VSTM) Reports Year-End 2015 Financial Results 3/3/2016 10:59:47 AM
Merck & Co. (MRK), Pfizer (PFE) And Verastem (VSTM) Announce Combination Trial Of Avelumab And VS-6063 In Ovarian Cancer 3/3/2016 10:56:19 AM
12345678910...
//-->